Oncology and Hematology

Episodes 49-64 of 295

Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
Project Oncology®
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
- Jody Takemoto, PhD
- Robert Wong, MD
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
CME/CE Broadcast Replay
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
1.00 credit
- Jennifer Caudle, DO
- Patricia A. Mangan, RN, MSN, APRN-BC
1.00 credit
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Project Oncology®
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
- Geoffrey B. Johnson, M.D., Ph.D.
A Look at the Utility of PSMA PET Scans in Prostate Cancer
A Look at the Utility of PSMA PET Scans in Prostate Cancer
Project Oncology®
A Look at the Utility of PSMA PET Scans in Prostate Cancer
- Jennifer Caudle, DO
- Geoffrey B. Johnson, M.D., Ph.D.
Diving into New Directions of Radiopharmaceuticals
Diving into New Directions of Radiopharmaceuticals
Project Oncology®
Diving into New Directions of Radiopharmaceuticals
- Brianna Cagle
Highlighting the Current Status and Future of Theranostics
Highlighting the Current Status and Future of Theranostics
Project Oncology®
Highlighting the Current Status and Future of Theranostics
- Geoffrey B. Johnson, M.D., Ph.D.
The Evolving AI Landscape in Nuclear Medicine
The Evolving AI Landscape in Nuclear Medicine
Project Oncology®
The Evolving AI Landscape in Nuclear Medicine
- Joyita Dutta
A Unique Look at the Current and Future Directions of Cancer Vaccines
A Unique Look at the Current and Future Directions of Cancer Vaccines
Project Oncology®
A Unique Look at the Current and Future Directions of Cancer Vaccines
- Lillian Siu, MD, FRCPC
A Look at the Horizon of Cancer Vaccines
A Look at the Horizon of Cancer Vaccines
Project Oncology®
A Look at the Horizon of Cancer Vaccines
- Lillian Siu, MD, FRCPC
MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis
MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis
Project Oncology®
MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis
- Brian P. McDonough, MD, FAAFP
- Nima Nabavizadeh, MD
- Tomasz Beer, MD, FACP
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
MinuteCE®
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
1.25 program credits
- Samuel J. Klempner, MD
1.25 program credits
Patients with HER2-low mBC: Discussing the Unmet Needs and Potential Improvements
Patients with HER2-low mBC: Discussing the Unmet Needs and Potential Improvements
Project Oncology®
Patients with HER2-low mBC: Discussing the Unmet Needs and Potential Improvements
- Pavani Chalasani, MD, MPH
- Virginia Kaklamani, MD
HER2-Low mBC: Optimizing Outcomes Through Patient-Centric Care
HER2-Low mBC: Optimizing Outcomes Through Patient-Centric Care
Project Oncology®
HER2-Low mBC: Optimizing Outcomes Through Patient-Centric Care
- Charles Turck, PharmD, BCPS, BCCCP
- Pavani Chalasani, MD, MPH
- Shipra Gandhi, MD
HER2-Low mBC and NCCN Guidelines: Providing Optimal Care for Patients
HER2-Low mBC and NCCN Guidelines: Providing Optimal Care for Patients
Project Oncology®
HER2-Low mBC and NCCN Guidelines: Providing Optimal Care for Patients
- Charles Turck, PharmD, BCPS, BCCCP
- Paolo Tarantino, MD
The Power of Patient Advocacy in Daily Clinical Practice
The Power of Patient Advocacy in Daily Clinical Practice
Project Oncology®
The Power of Patient Advocacy in Daily Clinical Practice
- Ashley L. Sumrall, MD
The Impact of Advocacy on Healthcare
The Impact of Advocacy on Healthcare
Project Oncology®
The Impact of Advocacy on Healthcare
- Ashley L. Sumrall, MD